Cochrane Database of Systematic Reviews 2012
DOI: 10.1002/14651858.cd008226.pub2
|View full text |Cite
|
Sign up to set email alerts
|

Lipid lowering efficacy of atorvastatin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
65
1
4

Year Published

2012
2012
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 93 publications
(73 citation statements)
references
References 396 publications
3
65
1
4
Order By: Relevance
“…An important component of hypertension management is cardiovascular risk reduction (28) . Clinical trial like ASCOT have reported that management of dyslipidemia using statins leads to greater reduction of clinical events as compared to isolated BP control (23) . In our study shows that majority of the patients with hypertension had comorbid dyslipidemia and Atorvastatin is the most commonly used lipid lowing agent among the Doctors (70.6%) in HEART study.…”
Section: Discussionmentioning
confidence: 99%
“…An important component of hypertension management is cardiovascular risk reduction (28) . Clinical trial like ASCOT have reported that management of dyslipidemia using statins leads to greater reduction of clinical events as compared to isolated BP control (23) . In our study shows that majority of the patients with hypertension had comorbid dyslipidemia and Atorvastatin is the most commonly used lipid lowing agent among the Doctors (70.6%) in HEART study.…”
Section: Discussionmentioning
confidence: 99%
“…However, on the basis of the limited information available regarding the effect of higher doses of atorvastatin, our results are broadly similar with the findings of the Cochrane systematic review published in 2012. 187 Having confirmed the Cochrane estimates, we therefore used them for economic modelling (see Chapter 7).…”
Section: Discussionmentioning
confidence: 99%
“…The Cochrane systematic review examining the lipid-lowering efficacy of atorvastatin 187 estimated effects for different doses and modelled the dose-effect relationship. A comparison between these estimates and the ones obtained in the present chapter can be seen in Figure 20 for TC and LDL cholesterol.…”
Section: Meta-analysis Of the Effect Of Atorvastatin On Serum Lipid Lmentioning
confidence: 99%
See 2 more Smart Citations